Population Pharmacokinetics of Commonly Used Antimicrobial Agents in Children of Bacterial Meningitis With Augmented Renal Clearance

Inclusion Criteria: * Children have been diagnosed with bacterial meningitis with augmented renal clearance (eGFR ≥ 160 mL/(min\*1.73m2)); * Age: 2 months-18 years; * Meropenem, vancomycin, ceftazidime, ceftriaxone, ceftizoxime and/ or linezolid used as part of regular treatment; * Meropenem, vancomycin, ceftazidime, ceftriaxone, ceftizoxime and linezolid was administered intravenously. Exclusion Criteria: * Patients who die within the treatment cycle; * Severe congenital malformation; * Receive other systemic experimental drug therapy; * Other factors that the researchers consider unsuitable for inclusion.